Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 56-61

  Newville, Howard ^a   Roley, Jason ^b   Sorensen, James L ^b  

^a Mount Sinai University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiretroviral therapy; HIV; Prescription medication misuse

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; ANTIRETROVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; METHADONE; OPIATE; PRESCRIPTION DRUG; SEDATIVE AGENT; TRANQUILIZER;

ADULT; ALCOHOL ABUSE; ARTICLE; DRINKING BEHAVIOR; DRUG MISUSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; HIV INFECTIONS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUG MISUSE; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 84922767252     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.013     Document Type: Article

References (60)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 1994, (Washington, DC). 4th ed.
2. Arnsten J.H., Demas P.A., Grant R.W., Gourevicth M.N., Farzadegan H., Howard A.A., et al. Impact of active substance use on antiretroviral therapy adherence and viral suppression in HIV-infected substance users. Journal of General Internal Medicine 2002, 17(5):377-381.
3. Ashton H. The diagnosis and management of benzodiazepine dependence. Current Opinion on Psychiatry 2005, 18:249-255.
4. Barker M.J., Greenwood K.M., Jackson M., Crowe S.F. Cognitive effects of long-term benzodiazepine use: A meta-analysis. CNS Drugs 2004, 18(1):37-48.
5. Beck A.T., Steer R.A., Brown G.K. BDI-II, Beck depression inventory: Manual 1996, Harcourt Brace, Boston. 2nd ed.
6. Becker W.C., Tobin D.G., Fiellin D.A. Nonmedical use of opioid analgesics obtained directly from physicians: Prevalence and correlates. Archives of Internal Medicine 2011, 171(11):1034-1036. 10.1001/archinternmed.2011.217.
7. Benotsch E.G., Koester S., Martin A.M., Cejka A., Luckman D., Jeffers A.J. Intentional misuse of over-the-counter medications, mental health, and polysubstance use in young adults. Journal of Community Health 2013, 10.1007/s10900-013-9811-9.
8. Benotsch E.G., Martin A.M., Koester S., Cejka A., Luckman D. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sexually Transmitted Diseases 2011, 38(2):105-110.
9. Benotsch E.G., Zimmerman R., Cathers L., McNulty S., Pierce J., Heck T., et al. Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults. Drug and Alcohol Dependence 2013, 132(1-2):391-394. 10.1016/j.drugalcdep.2013.02.027.
10. Berg K.M., Demas P.A., Howard A.A., Schoenbaum E.E., Gourevitch M.N., Arnsten J.H. Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine 2004, 19(11):1111-1117.
11. Blanco C., Rafful C., Wall M.M., Jin C.J., Kerridge B., Schwartz R.P. The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: A national study. Drug and Alcohol Dependence 2013, 133(2):473-479. 10.1016/j.drugalcdep.2013.07.011.
12. Boyd C.J., Teter C.J., West B.T., Morales M., McCabe S.E. Non-medical use of prescription analgesics: A three-year national longitudinal study. Journal of Addictive Diseases 2009, 28(3):232-242. 10.1080/10550880903028452.
13. Cacciola J.S., Alterman A.I., McLellan A.T., Lin Y.T., Lynch K.G. Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug and Alcohol Dependence 2007, 87(2-3):297-302. 10.1016/j.drugalcdep.2006.09.002.
14. Carr A., Cooper D.A. Adverse effects of antiretroviral therapy. Lancet 2000, 356(9239):1423-1430. 10.1016/s0140-6736(00)02854-3.
15. Centers for Disease Control and Prevention (CDC) Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. Morbidity and Mortality Weekly Report 2011, 60(43):1487-1492.
16. Chou R., Ballantyne J.C., Fanciullo G.J., Fine P.G., Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. Journal of Pain 2009, 10(2):147-159. 10.1016/j.jpain.2008.10.007.
17. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain 2009, 10(2):113-130. 10.1016/j.jpain.2008.10.008.
18. Chou R., Fanciullo G.J., Fine P.G., Miaskowski C., Passik S.D., Portenoy R.K. Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. Journal of Pain 2009, 10(2):131-146. 10.1016/j.jpain.2008.10.009.
19. Dozois D.J., Dobson K.S., Ahnberg J.L. A psychometric evaluation of the Beck Depression Inventory-II. Psychological Assessment 1998, 10:83-89.
20. Ersek M., Cherrier M.M., Overman S.S., Irving G.A. The cognitive effects of opioids. Pain Management Nursing 2004, 5(2):75-93.
21. Giordano T.P., Guzman D., Clark R., Charlebois E.D., Bangsberg D.R. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials 2004, 5(2):74-79.
22. Gross M., Holte S.E., Marmor M., Mwatha A., Koblin B.A., Mayer K.H. Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. Journal of Acquired Immune Deficiency Syndromes 2000, 24(4):393-398.
23. Hahn J.A., Samet J.H. Alcohol and HIV disease progression: Weighing the evidence. Current HIV/AIDS Reports 2010, 7(4):226-233. 10.1007/s11904-010-0060-6.
24. Hansen L., Penko J., Guzman D., Bangsberg D.R., Miaskowski C., Kushel M.B. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. Journal of Pain and Symptom Management 2011, 42(6):893-902. 10.1016/j.jpainsymman.2011.02.026.
25. Hawkins T., Geist C., Young B., Giblin A., Mercier R.C., Thornton K., et al. Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients. HIV Clinical Trials 2005, 6(4):187-196. 10.1310/92VR-FP24-J8GA-B49Q.
26. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006, 67(7):1062-1073.
27. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., Malone R.M., Perhac J.S., Potisek N.M., et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research 2006, 6:46. 10.1186/1472-6963-6-46.
28. Jeevanjee S., Penko J., Guzman D., Miaskowski C., Bangsberg D.R., Kushel M.B. Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-Infected indigent adults in San Francisco. AIDS Behavior 2014, 18(7):1352-1358.
29. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the future national survey results on drug use, 1975-2006: Volume I, Secondary school students 2007, National Institute on Drug Abuse, Bethesda, MD, (NIH Publication No. 07-6205).
30. Kecojevic A., Wong C.F., Schrager S.M., Silva K., Jackson Bloom J., Iverson E., et al. Initiation into prescription drug misuse: Differences between lesbian, gay, bisexual, transgender (LGBT) and heterosexual high-risk young adults in Los Angeles and New York. Addictive Behaviors 2012, 37(11):1289-1293.
31. Kelly B.C., Parsons J.T. Prevalence and predictors of non-medical prescription drug use among men who have sex with men. Addictive Behaviors 2010, 35(4):312-317. 10.1016/j.addbeh.2009.11.002.
32. Lochet P., Peyrière H., Lotthé A., Mauboussin J.M., Delmas B., Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Medicine 2003, 4(1):62-66. 10.1046/j.1468-1293.2003.00136.x.
33. Lum P.J., Little S., Botsko M., Hersh D., Thawley R.E., Egan J.E., et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abouse in HIV primary care settings. Journal of Acquired Immune Deficiency Syndromes 2011, 56(SUPPL. 1):S91-S97. 10.1097/QAI.0b013e31820a9a82.
34. Martinez A.N., D'Amico E.J., Kral A.H., Bluthenthal R.N. Nonmedical prescription drug use among injection drug users. Journal of Drug Issues 2012, 42(3):216-225.
35. Max B., Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clinical Infectious Diseases 2000, 30(SUPPL. 2):S96-S116. 10.1086/313859.
36. McCabe S.E., Cranford J.A., Boyd C.J. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: Prevalence of co-occurrence in a national sample. Drug and Alcohol Dependence 2006, 84(3):281-288.
37. McCabe S.E., Cranford J.A., Morales M., Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drug: Prevalence, correlates, and consequences. Journal of Studies on Alcohol 2006, 67(4):529-537.
38. McCabe S.E., West B.T., Morales M., Cranford J.A., Boyd C.J. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007, 102(12):1920-1930. 10.1111/j.1360-0443.2007.02015.x.
39. McLellan A.T., Cacciola J.S., Zanis D. The Addiction Severity Index-"Lite" (ASI-"Lite") 1997, Center for the Studies of Addiction, University of Pennsylvania/Philadelphia VA Medical Center.
40. Metzger D.S., Koblin B., Turner C., Navaline H., Valenti F., Holte S., et al. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. American Journal of Epidemiology 2000, 152(2):99-106.
41. Newville H., Sorensen J.L. The efficacy of a computerized assessment of medication adherence in active substance users. Journal of the International Association of Providers of AIDS Care 2013, 12(4):232-235. 10.1177/2325957413488206.
42. Novak S.P., Herman-Stahl M., Flannery B., Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug and Alcohol Dependence 2009, 100(1-2):63-70. 10.1016/j.drugalcdep.2008.09.013.
43. Prejean J., Song R., Hernandez A., Ziebell R., Green T., Walker F., et al. Estimated HIV incidence in the United States, 2006-2009. PLoS ONE 2011, 6(8):e17502. 10.1371/journal.pone.0017502.
44. Rapeli P., Fabritius C., Kalska H., Alho H. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clinical Pharmacology 2011, 11:13. 10.1186/1472-6904-11-13.
45. Reust C.E. Common adverse effects of antiretroviral therapy for HIV disease. American Family Physician 2011, 83(12):1443-1451.
46. Robinson-Papp J., Elliott K., Simpson D.M., Morgello S. Problematic prescription opioid use in an HIV-infected cohort: The importance of universal toxicology testing. Journal of Acquired Immune Deficiency Syndromes 2012, 61(2):187-193. 10.1097/QAI.0b013e3182683c98.
47. Roux P., Carrieri P.M., Cohen J., Ravaux I., Spire B., Gossop M., et al. Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: The need for a more comprehensive approach. Harm Reduction Journal 2011, 8:31.
48. SAMHSA Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of national findings. NSDUH series 2012, H-44. Substance Abuse and Mental Health Services Administration, Rockville, (HHS publication no.(SMA) 12-4713).
49. Schepis T.S., Hakes J.K. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 2011, 106(12):2146-2155. 10.1111/j.1360-0443.2011.03520.x.
50. Substance Abuse and Mental Health Services Administration Results from the 2006 National Survey on Drug Use and Health: National findings. NSDUH Series 2007, H-32. Office of Applied Studies, Rockville, MD, (DHHS Publication No. SMA 07-4293).
51. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., Sullivan L.E. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 2008, 103(2):258-268. 10.1111/j.1360-0443.2007.02056.x.
52. Treisman G.J., Kaplin A.I. Neurologic & psychiatric complications in HIV & antiretroviral drugs. AIDS 2002, 16:1201-1215.
53. Tsao J.C., Plankey M.W., Young M.A. Pain, psychological symptoms and prescription drug misuse in HIV: A literature review. Journal of pain and Symptom Management 2012, 5(2):111-118.
54. Tsao J.C., Stein J.A., Dobalian A. Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV. Pain 2007, 133(1-3):128-137. 10.1016/j.pain.2007.03.016.
55. Turjanski N., Lloyd G.G. Psychiatric side-effects of medications: Recent developments. Advances in Psychiatric Treatment 2005, 11:58-70. 10.1192/apt.11.1.58.
56. Turk D.C., Swanson K.S., Gatchel R.J. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clinical Journal of Pain 2008, 24(6):497-508. 10.1097/AJP.0b013e31816b1070.
57. Veilleux J.C., Colvin P.J., Anderson J., York C., Heinz A.J. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review 2010, 30(2):155-166.
58. Vijayaraghavan M., Penko J., Bangsberg D.R., Miaskowski C., Kushel M.B. Opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. JAMA Internal Medicine 2013, 173(3):235-237. 10.1001/jamainternmed.2013.1576.
59. Wasan A.D., Butler S.F., Budman S.H., Benoit C., Fernandez K., Jamison R.N. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clinical Journal of Pain 2007, 23(4):307-315. 10.1097/AJP.0b013e3180330dc5.
60. Wu A.W., Revicki D.A., Jacobson D., Malitz F.E. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research 1997, 6(6):481-493.